According to the new market research report dPCR and qPCR Market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8%. The rising incidences of target diseases (such as HIV, malaria, tuberculosis, and cancer) and …
Global Market Dynamics Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the In situ Hybridization Market in the coming years. Industry Segmentation: By application, the in situ hybridization market …
Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.) Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech …
According to the new market research report ” Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category – Forecasts to 2021 “, published by MarketsandMarkets™, The global vaccine adjuvants …
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Factors such as growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to …
The increasing demand for biopharmaceuticals, increasing R&D expenditure in the biopharmaceutical industry, significant benefits of membrane chromatography over conventional chromatography methods, and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are some the factors driving the growth of this market. The global …
The antibody production market comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration. The global market is projected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of …
The global PDX models market is projected to reach USD 167.6 million by 2022 from USD 77.4 million in 2017, at a CAGR of 16.7%. Factors such as growing demand for personalized medicine, continuous support for cancer research from the public as well as private …
Immunofluorescence assay is a powerful technique used to analyze the distribution of glycans, proteins, and small biological and non-biological molecules (cells and tissues) using antibodies conjugated with a fluorescent dye, known as fluorophore, which can be visualized using a fluorescence microscope or imaging systems. The Immunofluorescence …
Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and …
The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers. The global Cell Counting market is expected to grow …
Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global Human Microbiome Market. The market is an emerging market with abundant …
The emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the market, which is driven by growing healthcare infrastructure, vast population pool, rising demand for quality care, and the increasing healthcare spending. The global Nurse …
Pyrogens are molecular products of microbial origin that induce immunologic reaction in humans or test animals when administered parenterally. Pyrogen testing is used by pharmaceutical, biotechnological companies and medical devices companies to ensure the absence of these toxic molecular products. The major drivers for the …